RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1 - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue JNCI: Journal of the National Cancer Institute Année : 2023

RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1

Dates et versions

hal-04390880 , version 1 (12-01-2024)

Identifiants

Citer

François Bertucci, Alexandre de Nonneville, Pascal Finetti, Emilie Mamessier. RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1. JNCI: Journal of the National Cancer Institute, 2023, 115 (6), pp.762-763. ⟨10.1093/jnci/djad060⟩. ⟨hal-04390880⟩

Collections

CNRS UNIV-AMU CRCM
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More